Document Detail


Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study.
MedLine Citation:
PMID:  19508994     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIMS: It has been demonstrated that, in comparison with bare-metal stents (BMS), sirolimus-eluting stents (SES) reduce restenosis after the percutaneous revascularization of small coronary arteries, but the long-term clinical outcomes of this treatment have not yet been investigated. METHODS AND RESULTS: The long-term SES-SMART clinical study was a multicentre, prospective, randomized, single-blind study of 257 patients receiving a SES or BMS in a small coronary artery, who were evaluated at discharge, 30 days, 8 and 24 months after stenting. The clinical endpoint of the study was a 24 months composite of major adverse cardiac and cerebrovascular events, which included death, non-fatal myocardial infarction, ischaemia-driven target lesion revascularization (TLR), and cerebrovascular accident. The 24 months follow-up was completed by 254 patients (98.8%). The use of SES was associated with a significantly lower incidence of the clinical endpoint (12.6% vs. 33.1%; HR 0.30, 95% CI: 0.17-0.55; P < 0.0001), which was not only due to a reduction in TLR (7.9% vs. 29.9%; HR 0.30, 95% CI: 0.16-0.59; P < 0.0001), but also to a reduction in myocardial infarction (1.6% vs. 10.2%; HR 0.09, 95% CI: 0.01-0.66; P = 0.018). CONCLUSION: In comparison with BMS, the use of SES in the percutaneous revascularization of small coronary arteries is associated with improved clinical outcomes after 2 years follow-up.
Authors:
Alberto Menozzi; Emilia Solinas; Paolo Ortolani; Alessandra Repetto; Francesco Saia; Giancarlo Piovaccari; Antonio Manari; Enrico Magagnini; Luigi Vignali; Erminio Bonizzoni; Piera Angelica Merlini; Claudio Cavallini; Diego Ardissino;
Related Documents :
17086534 - A new technique to anchor stents for exact placement in ostial stenoses: the stent tail...
12357534 - Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduce...
1499944 - Identification of an abnormal esophageal clearance response to intraluminal distention ...
11081614 - Biodegradable external tracheal stents and their use in a rabbit tracheal reconstructio...
2803874 - Superior qrs axis in ventricular septal defect.
23297764 - A molecular and genetic outline of cardiac morphogenesis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-06-09
Journal Detail:
Title:  European heart journal     Volume:  30     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  2095-101     Citation Subset:  IM    
Affiliation:
Unità Operativa di Cardiologia, Dipartimento Cardio-Polmonare, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy. almenozzi@ao.pr.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tuberculosis: value of lateral chest radiography in pre-employment screening of patients with positi...
Next Document:  Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplan...